• Je něco špatně v tomto záznamu ?

Polypharmacy in nursing home in Europe: results from the SHELTER study

Graziano Onder, Rosa Liperoti, Daniela Fialova, Eva Topinkova, Matteo Tosato, Paola Danese, Pietro Folino Gallo, Iain Carpenter, Harriet Finne-Soveri, Jacob Gindin, Roberto Bernabei and Francesco Landi for the SHELTER Project

. 2012 ; 67 (6) : 698-704.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14072568

Grantová podpora
NS10029 MZ0 CEP - Centrální evidence projektů

BACKGROUND: This study assesses prevalence and patients characteristics related to polypharmacy in a sample of nursing home residents. METHODS: We conducted a cross-sectional analysis on 4,023 nursing home residents participating to the Services and Health for Elderly in Long TERm care (SHELTER) project, a study collecting information on residents admitted to 57 nursing home in 8 countries. Data were collected using the interRAI instrument for long-term care facilities. Polypharmacy status was categorized in 3 groups: non-polypharmacy (0-4 drugs), polypharmacy (5-9 drugs) and excessive polypharmacy (> 10 drugs). RESULTS: Polypharmacy was observed in 2,000 (49.7%) residents and excessive polypharmacy in 979 (24.3%) residents. As compared with non-polypharmacy, excessive polypharmacy was directly associated not only with presence of chronic diseases but also with depression (odds ratio [OR] 1.81; 95% confidence interval [CI] 1.38-2.37), pain (OR 2.31; 95% CI 1.80-2.97), dyspnoea (OR 2.29; 95% CI 1.61-3.27), and gastrointestinal symptoms (OR 1.73; 95% CI 1.35-2.21). An inverse association with excessive polypharmacy was shown for age (OR for 10 years increment 0.85; 95% CI 0.74-0.96), activities of daily living disability (OR for assistance required vs independent 0.90; 95% CI 0.64-1.26; OR for dependent vs independent 0.59; 95% CI 0.40-0.86), and cognitive impairment (OR for mild or moderate vs intact 0.64; 95% CI 0.47-0.88; OR for severe vs intact 0.39; 95% CI 0.26-0.57). CONCLUSIONS: Polypharmacy and excessive polypharmacy are common among nursing home residents in Europe. Determinants of polypharmacy status include not only comorbidity but also specific symptoms, age, functional, and cognitive status.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14072568
003      
CZ-PrNML
005      
20190104111209.0
007      
ta
008      
140923s2012 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1093/gerona/glr233 $2 doi
035    __
$a (PubMed)22219520
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xxu
100    1_
$a Onder, Graziano $u Centro Medicina dell'Invecchiamento, Dipartimento di Scienze Gerontologiche, Geriatriche e Fisiatriche, Università Cattolica Sacro Cuore, Rome, Italy. graziano_onder@rm.unicatt.it
245    10
$a Polypharmacy in nursing home in Europe: results from the SHELTER study / $c Graziano Onder, Rosa Liperoti, Daniela Fialova, Eva Topinkova, Matteo Tosato, Paola Danese, Pietro Folino Gallo, Iain Carpenter, Harriet Finne-Soveri, Jacob Gindin, Roberto Bernabei and Francesco Landi for the SHELTER Project
520    9_
$a BACKGROUND: This study assesses prevalence and patients characteristics related to polypharmacy in a sample of nursing home residents. METHODS: We conducted a cross-sectional analysis on 4,023 nursing home residents participating to the Services and Health for Elderly in Long TERm care (SHELTER) project, a study collecting information on residents admitted to 57 nursing home in 8 countries. Data were collected using the interRAI instrument for long-term care facilities. Polypharmacy status was categorized in 3 groups: non-polypharmacy (0-4 drugs), polypharmacy (5-9 drugs) and excessive polypharmacy (> 10 drugs). RESULTS: Polypharmacy was observed in 2,000 (49.7%) residents and excessive polypharmacy in 979 (24.3%) residents. As compared with non-polypharmacy, excessive polypharmacy was directly associated not only with presence of chronic diseases but also with depression (odds ratio [OR] 1.81; 95% confidence interval [CI] 1.38-2.37), pain (OR 2.31; 95% CI 1.80-2.97), dyspnoea (OR 2.29; 95% CI 1.61-3.27), and gastrointestinal symptoms (OR 1.73; 95% CI 1.35-2.21). An inverse association with excessive polypharmacy was shown for age (OR for 10 years increment 0.85; 95% CI 0.74-0.96), activities of daily living disability (OR for assistance required vs independent 0.90; 95% CI 0.64-1.26; OR for dependent vs independent 0.59; 95% CI 0.40-0.86), and cognitive impairment (OR for mild or moderate vs intact 0.64; 95% CI 0.47-0.88; OR for severe vs intact 0.39; 95% CI 0.26-0.57). CONCLUSIONS: Polypharmacy and excessive polypharmacy are common among nursing home residents in Europe. Determinants of polypharmacy status include not only comorbidity but also specific symptoms, age, functional, and cognitive status.
590    __
$a bohemika - dle Pubmed
650    02
$a činnosti denního života $7 D000203
650    02
$a senioři $7 D000368
650    02
$a senioři nad 80 let $7 D000369
650    02
$a chronická nemoc $7 D002908
650    02
$a kognitivní poruchy $x farmakoterapie $7 D003072
650    02
$a průřezové studie $7 D003430
650    02
$a deprese $x epidemiologie $x farmakoterapie $7 D003863
650    02
$a dyspnoe $x epidemiologie $x farmakoterapie $7 D004417
650    02
$a ženské pohlaví $7 D005260
650    02
$a gastrointestinální nemoci $x farmakoterapie $7 D005767
650    12
$a průzkumy zdravotní péče $x statistika a číselné údaje $7 D019538
650    02
$a zdravotní služby pro seniory $x statistika a číselné údaje $7 D006299
650    12
$a domovy pro seniory $x statistika a číselné údaje $7 D006707
650    02
$a lidé $7 D006801
650    02
$a dlouhodobá péče $x statistika a číselné údaje $7 D008134
650    02
$a mužské pohlaví $7 D008297
650    12
$a pečovatelské domovy $x statistika a číselné údaje $7 D009735
650    12
$a polypharmacy $7 D019338
650    02
$a prevalence $7 D015995
650    02
$a stupeň závažnosti nemoci $7 D012720
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Liperoti, Rosa $u Centro Medicina dell'Invecchiamento, Dipartimento di Scienze Gerontologiche, Geriatriche e Fisiatriche, Università Cattolica Sacro Cuore, Rome, Italy
700    1_
$a Fialová, Daniela $7 xx0074268 $u Department of Geriatrics and Gerontology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Topinková, Eva, $d 1953- $7 nlk20020113720 $u Department of Geriatrics and Gerontology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Tosato, Matteo $u Centro Medicina dell'Invecchiamento, Dipartimento di Scienze Gerontologiche, Geriatriche e Fisiatriche, Università Cattolica Sacro Cuore, Rome, Italy
700    1_
$a Danese, Paola $u Centro Medicina dell'Invecchiamento, Dipartimento di Scienze Gerontologiche, Geriatriche e Fisiatriche, Università Cattolica Sacro Cuore, Rome, Italy
700    1_
$a Gallo, Pietro Folino $u Medicines Utilisation and Expenditure and HTA Unit - Italian Medicines Agency (AIFA), Rome, Italy
700    1_
$a Carpenter, Iain $u Centre for Health Services Studies, University of Kent, UK
700    1_
$a Finne-Soveri, Harriet $u National Institute for Health and Welfare, Helsinki, Finland
700    1_
$a Gindin, Jacob $u Laboratory of Research in Geriatrics and Gerontology, University of Haifa, Israel
700    1_
$a Bernabei, Roberto $u Centro Medicina dell'Invecchiamento, Dipartimento di Scienze Gerontologiche, Geriatriche e Fisiatriche, Università Cattolica Sacro Cuore, Rome, Italy
700    1_
$a Landi, Francesco $u Centro Medicina dell'Invecchiamento, Dipartimento di Scienze Gerontologiche, Geriatriche e Fisiatriche, Università Cattolica Sacro Cuore, Rome, Italy
773    0_
$t Journal of gerontology $x 0022-1422 $g Roč. 67, č. 6 (2012), s. 698-704 $w MED00010015
910    __
$a ABA008 $b x $y 4 $z 0
990    __
$a 20140923161905 $b ABA008
991    __
$a 20190104111404 $b ABA008
999    __
$a ok $b bmc $g 1040413 $s 871458
BAS    __
$a 3
BMC    __
$a 2012 $b 67 $c 6 $d 698-704 $i 0022-1422 $m Journal of gerontology $x MED00010015 $n J Gerontol
GRA    __
$a NS10029 $p MZ0
LZP    __
$a 2014-09/abme

Najít záznam

Citační ukazatele

Možnosti archivace